(From the August 2016 Issue of MedStat)
Dean Lee, MD, PhD, has been named the director of the Cellular Therapy and Cancer Immunotherapy Program for Division of Hematology/Oncology/BMT and Center for Childhood Cancer and Blood Diseases at Nationwide Children’s. Dr. Lee will also serve as the director of Cellular Therapy at The Ohio State University Comprehensive Cancer Center, partnering with the clinical and research teams at the James Cancer Hospital and Solove Research Institute to translate immunotherapy approaches to treat adult cancer patients. The collaboration is dedicated to pursuing clinical trials and translational research to develop innovative immune treatments, including the use of advanced cellular therapy.
Previously, Dr. Lee was the section chief of Pediatric Cellular Therapy and associate professor at MD Anderson Cancer Center. Dr. Lee earned his bachelor’s degree in natural sciences from Fresno Pacific College and his medical and doctorate degrees in microbiology and molecular genetics from Loma Linda University. Remaining at Loma Linda to complete his pediatric residency training, Dr. Lee concluded his fellowship in pediatric hematology/oncology at Texas Children’s Hospital, Baylor College of Medicine.